Bispecific Antibody Market Size

Bispecific Antibody Market size was valued at USD 576.44 million in 2024 and is set to reach USD 1.41 billion by the end of 2037, registering around 7.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of bispecific antibody is assessed at USD 609.64 million.

The market is primarily driven by a rise in the number of cancer-afflicted people. Simply owing to population increase and aging, the worldwide burden of cancer is anticipated to rise to 27.5 million new cases and 16.3 million cancer deaths by 2040. Bispecific antibodies are a type of immunotherapy that has shown promising results in cancer treatment. Also, it can redirect and activate immune cells to specifically target cancer cells.

Besides this, rising facilities for rare diseases can facilitate access to bispecific antibodies for treatment. On May 4, 2023, the National Organization for Rare Disorders (NORD) unveiled the opening of nine additional Rare Disease Centers of Excellence, bringing the total number of medical facilities of NORD in the United States to 40. Rare diseases are typically associated with unmet medical needs, the establishment of specific facilities will increase the need for antibodies for the treatment of rare diseases.